- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2021–2026 · cooperative agreement · U01
Genomic control of gene regulatory networks governing early human lineage decisions
Michael A Beer · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
The gut endoderm: origin, formation and fate
Anna-Katerina Hadjantonakis · Kettering University · funded by National Institutes of Health
2021–2024 · career development · K99
Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions -supplement
Hanzhi Luo · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Impact of the aging niche on cancer phenotypes probed using mouse cancer models produced by somatic engineering.
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2021–2023 · fellowship · F32
The role and regulation of p53 in obesity-induced liver cancer
Changyu Zhu · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
A multi-faceted intervention to promote breast cancer hormone receptor testing in Tanzania
Dianna L. Ng · Kettering University · funded by National Institutes of Health
2021–2022 · fellowship · F31
Investigating the Role of DNMT3A mutations in the initiation and maintenance of myeloid malignancies
Michael R Waarts · Kettering University · funded by National Institutes of Health
2021–2022 · program · P30
Empathic communication skills training to reduce lung cancer stigma in Nigeria
Craig B Thompson · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors
Filemon S Dela Cruz · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
A Targeted Approach to the Surveillance of Precursor Lesions for Gastric Cancer
Monika Laszkowska · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Targeting immune suppressive microenvironment in ATC
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2023 · research · R21
A Pragmatic Randomized Control Trial of Nurse-Delivered Brief Meaning Centered Psychotherapy for Homebound Palliative Care Patients
Allison Applebaum · Kettering University · funded by National Institutes of Health
2021–2024 · fellowship · F31
Genetic Determinants of Evolutionary Trajectories and Clinical Course in Pancreatic Cancer
Katelyn Mullen · Kettering University · funded by National Institutes of Health
2021–2024 · research · R21
Investigation of the impact of pegylated Interferon on clonal trajectory and inflammatory cytokine production in MPN patients
Andrew Jeffrey Dunbar · Kettering University · funded by National Institutes of Health
2021–2025 · career development · K08
Investigating apoptotic priming as a determinant of sensitivity to leukemia-directed therapies
Sheng Cai · Kettering University · funded by National Institutes of Health
2021–2028 · research · R35
Novel therapeutic development for small cell lung cancer
Charles M. Rudin · Kettering University · funded by National Institutes of Health
2021–2024 · research · R01
T cell invasion of the stem cell compartment during immune-mediated GI damage
Alan M Hanash · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
A Phase 1 Trial of MLN0128 (sapanisertib) and CB-839 HCl (telaglenastat) in Advanced NSCLC Patients
Paul K Paik · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer
Ricardo Otazo · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Improving efficacy of radioiodine treatment of thyroid cancer
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2024 · research · R01
Investigating PolQ-mediated alternative NHEJ in breast cancer
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
Abraham Ari Hakimi · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Predicting sensitivity and resistance in RET-driven cancers
Alexander Drilon · Kettering University · funded by National Institutes of Health
2021–2025 · cooperative agreement · U01
Genomic control of gene regulatory networks governing early human lineage decisions
Michael A Beer · Kettering University · funded by National Institutes of Health
2021–2024 · career development · K99
Single cell quantification of genomic instability in cancer as a determinant of therapeutic response
Marc Williams · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer
Ricardo Otazo · Kettering University · funded by National Institutes of Health
2021–2026 · research · R35
Chemical and Physical Mechanisms of Wound Detection
Philipp Michael Niethammer · Kettering University · funded by National Institutes of Health
2021–2023 · career development · K99
Development of multimodal agents from natural spider peptides for prostate cancer via sodium-channel NaV1.7
Junior Arturo Gonzales-Arevalo · Kettering University · funded by National Institutes of Health
2021–2026 · research · R35
Sizing and Scaling in Functional Muscle Cells
Mary K Baylies · Kettering University · funded by National Institutes of Health
2021–2023 · research · R56
Selective interactome vulnerability across the Alzheimer’s disease spectrum
Gabriela Chiosis · Kettering University · funded by National Institutes of Health
2021–2023 · fellowship · F32
The role and regulation of p53 in obesity-induced liver cancer
Changyu Zhu · Kettering University · funded by National Institutes of Health
2021–2024 · research · R21
Patient-derived organoids reveal rectal cancers develop radiosensitivity
Richard N Kolesnick · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Transcriptional control of NK cell metabolism
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Targeting immune suppressive microenvironment in ATC
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2024 · fellowship · F32
Metabolic determinants of metastatic heterogeneity: quantitative experiments and mathematical models
Deepti Mathur · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
Mechanisms of lysosomal ion transport proteins involved in pH homeostasis
Richard Kevin Hite · Kettering University · funded by National Institutes of Health
2021–2027 · career development · K00
Dissecting mechanisms of inflammation driven cancer susceptibility in epithelial barrier tissues
Christopher Cowley · Kettering University · funded by National Institutes of Health
2021–2023 · research · R21
Functional analysis of the immune landscape in IDH mutant gliomas
Viviane Tabar · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
A Targeted Approach to the Surveillance of Precursor Lesions for Gastric Cancer
Monika Laszkowska · Kettering University · funded by National Institutes of Health